9.38
2.51%
+0.23
Zymeworks Inc. Aktie (ZYME) Neueste Nachrichten
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME) - Business Wire
Business Wire
Zymeworks BC Inc (ZYME) deserves deeper analysis – US Post News - US Post News
US Post News
Taking a Closer Look At Zymeworks BC Inc (ZYME) Following Its Recent Trade – Knox Daily - Knox Daily
Knox Daily
Zymeworks (ZYME) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
Zymeworks (NYSE:ZYME) Rating Reiterated by HC Wainwright - Defense World
Defense World
Zymeworks (NYSE:ZYME) Rating Reiterated by HC Wainwright - Defense World
Defense World
Zymeworks Inc. (ZYME) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Movies UK
Yahoo Movies UK
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Benzinga
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - Zymeworks (NASDAQ:ZYME) - Benzinga
Benzinga
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME - PR Newswire
PR Newswire
Take off with Zymeworks BC Inc (ZYME): Get ready for trading – Sete News - SETE News
SETE News
How Much Upside is Left in Zymeworks Inc. (ZYME)? Wall Street Analysts Think 65.75% - Yahoo New Zealand News
Yahoo New Zealand News
Zymeworks (NYSE:ZYME) PT Lowered to $12.00 at Wells Fargo & Company - Defense World
Defense World
Zymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance
Yahoo Finance
Zymeworks First Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Simply Wall St
Earnings call: Zymeworks outlines clinical strategy and financial health - Investing.com
Investing.com
Zymeworks Inc.'s (NASDAQ:ZYME) Shares Lagging The Industry But So Is The Business - Simply Wall St
Simply Wall St
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates - Zacks Investment Research
Zacks Investment Research
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
Zymeworks Touts Financial Health and R&D Progress - TipRanks.com - TipRanks
TipRanks
Zymeworks Inc Stresses Transparency in Investor Communications - TipRanks.com - TipRanks
TipRanks
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results - Yahoo Finance
Yahoo Finance
Zymeworks Engages in Key Investor Conferences - TipRanks.com - TipRanks
TipRanks
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire Inc.
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire
GlobeNewswire
Buy Zymeworks Pioneering Cancer Treatments: Zanidatamab's Promising Data (NASDAQ:ZYME) - Seeking Alpha
Seeking Alpha
Zymeworks Announces Upcoming Financial Report - TipRanks.com - TipRanks
TipRanks
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
GlobeNewswire Inc.
Zymeworks (ZYME) Loses -13.41% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks Investment Research
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
GlobeNewswire Inc.
Zymeworks Unveils Promising Cancer Research - TipRanks.com - TipRanks
TipRanks
Zymeworks CFO Dr. Astle Exits with Severance Package - TipRanks.com - TipRanks
TipRanks
ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks ... - GlobeNewswire
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME) - GlobeNewswire
GlobeNewswire
Zymeworks appoints interim CFO after sudden removal By Investing.com - Investing.com
Investing.com
Zymeworks Inc. Strengthens Board with Dr. Gallagher's Appointment - TipRanks.com - TipRanks
TipRanks
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
GlobeNewswire Inc.
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors - Yahoo Finance
Yahoo Finance
Zymeworks Engages Investors in April Conferences - TipRanks.com - TipRanks
TipRanks
Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire Inc.
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire
GlobeNewswire
Zymeworks (ZYME) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
Zymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates
Zacks Investment Research
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Zymeworks Poised for Growth with Strong Cash Position - TipRanks.com - TipRanks
TipRanks
Zymeworks Highlights Cancer Therapeutics at AACR - TipRanks.com - TipRanks
TipRanks
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
GlobeNewswire Inc.
Zymeworks: A Strong Buy Amidst Zanidatamab's Promising Developments (NASDAQ:ZYME) - Seeking Alpha
Seeking Alpha
Kapitalisierung:
|
Volumen (24h):